Didier Pruneau

Release of Bradykinin and Expression of Kinin B₂ Receptors in the Brain: Role for Cell Death and Brain Edema Formation After Focal Cerebral Ischemia in Mice

Moritz Gröger, Diane Lebesgue, Didier Pruneau et al. · Journal of Cerebral Blood Flow & Metabolism · 2005 · 136 citations

Life Sciences, Neuroscience, Pharmacology +17

Optogenetic therapy: high spatiotemporal resolution and pattern discrimination compatible with vision restoration in non-human primates

Grégory Gauvain, Himanshu Akolkar, Antoine Chaffiol et al. · Communications Biology · 2021 · 126 citations · Full text

Medicine, Biotechnology, Ophthalmology +17

Pharmacological profile of LF 16-0687, a new potent non-peptide bradykinin B2 receptor antagonist

Didier Pruneau, Jean Luc Paquet, J.M. Luccarini et al. · Immunopharmacology · 1999 · 94 citations

Medicine, Medicinal Chemistry, Pharmacology +4

Effects of LF 16-0687 Ms, a bradykinin B2 receptor antagonist, on brain edema formation and tissue damage in a rat model of temporary focal cerebral ischemia

Stefan Zausinger, David B. Lumenta, Didier Pruneau et al. · Brain Research · 2002 · 71 citations

Medicine, Neuroscience, Pharmacology +17

Comparison of contractile responses to 5‐hydroxytryptamine and sumatriptan in human isolated coronary artery: synergy with the thromboxane A₂‐receptor agonist, U46619

Thomas M. Cocks, B. Kemp, Didier Pruneau et al. · British Journal of Pharmacology · 1993 · 69 citations · Full text

Medicine, Cardiology, Pharmacology +14